Mark N. Kirstein PharmD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Oxaliplatin (OX) is increasingly used for hyperthermic intraperitoneal chemotherapy (HIPC) for patients with peritoneal metastases. Our aim was to review electrolyte disturbances and complications after HIPC with oxaliplatin (OX) versus mitomycin C (MMC). We included patients enrolled in single-institution prospective clinical trials who underwent(More)
  • 1